BenQ Medical Technology (4116) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BenQ Medical Technology (4116) has a cash flow conversion efficiency ratio of 0.084x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$179.07 Million ≈ $5.64 Million USD) by net assets (NT$2.12 Billion ≈ $66.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BenQ Medical Technology defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
BenQ Medical Technology - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how BenQ Medical Technology's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BenQ Medical Technology Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BenQ Medical Technology ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gujarat Apollo Industries Limited
NSE:GUJAPOLLO
|
-0.009x |
|
Top Win International Limited
NASDAQ:SORA
|
-0.540x |
|
Aeon Motor Co Ltd
TWO:1599
|
0.066x |
|
Shin Tai Industry Co Ltd
TW:1235
|
-0.015x |
|
M K Land Holdings Bhd
KLSE:8893
|
-0.012x |
|
Daiyang Metal
KO:009190
|
-0.016x |
|
ARSS Infrastructure Projects Limited
NSE:ARSSINFRA
|
-4.011x |
|
BitFuFu Inc. Class A Ordinary Shares
NASDAQ:FUFU
|
0.000x |
Annual Cash Flow Conversion Efficiency for BenQ Medical Technology (2017–2024)
The table below shows the annual cash flow conversion efficiency of BenQ Medical Technology from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 4116 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$2.30 Billion ≈ $72.47 Million |
NT$222.22 Million ≈ $7.00 Million |
0.097x | -52.38% |
| 2023-12-31 | NT$2.18 Billion ≈ $68.69 Million |
NT$442.35 Million ≈ $13.94 Million |
0.203x | -6.99% |
| 2022-12-31 | NT$1.74 Billion ≈ $54.71 Million |
NT$378.77 Million ≈ $11.93 Million |
0.218x | +97.69% |
| 2021-12-31 | NT$1.10 Billion ≈ $34.65 Million |
NT$121.35 Million ≈ $3.82 Million |
0.110x | -18.63% |
| 2020-12-31 | NT$1.12 Billion ≈ $35.20 Million |
NT$151.48 Million ≈ $4.77 Million |
0.136x | -11.39% |
| 2019-12-31 | NT$1.11 Billion ≈ $34.84 Million |
NT$169.23 Million ≈ $5.33 Million |
0.153x | +32.57% |
| 2018-12-31 | NT$1.09 Billion ≈ $34.42 Million |
NT$126.10 Million ≈ $3.97 Million |
0.115x | +68.85% |
| 2017-12-31 | NT$1.07 Billion ≈ $33.63 Million |
NT$72.97 Million ≈ $2.30 Million |
0.068x | -- |
About BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the… Read more